Generex Biotechnology Corporation

(NASDAQ:GNBT)
  Oct 31, 2008 Jul 31, 2008 Apr 30, 2008 Jan 31, 2008
Operating revenue
Total Revenue 538 60 2 19
Operating Revenue 538 60 2 19
Adjustments To Revenue — — — —
Cost Of Sales -4,358 -3,441 -706 -287
Cost Of Sales With Depreciation 22 26 1 6
Gross Operating Profit 4,896 3,501 708 306
Operating Expenses
Research And Development Expenses 4,356 4,738 4,303 3,470
Selling General And Administrative Expenses 3,685 4,355 5,550 3,371
Advertising Expenses — — — —
Operating Income Before Depreciation -3,145 -5,592 -9,145 -6,535
Operating Income -7,525 -9,059 -9,852 -6,828
Depreciation 4,380 3,467 707 293
Depreciation Unreconciled — — — —
Amortization — — — —
Amortization Of Intangibles — — — —
Operating Income After Depreciation -7,525 -9,059 -9,852 -6,828
Non Operating Expenses
Interest Expense 4,429 3,555 609 59
Pre Tax Income -11,697 -12,326 -10,174 -6,507
Income Taxes — — — —
Minority Interest — — — —
Income Before Income Taxes — — — —
Net Income From Continuing Operations -11,697 -12,326 -10,174 -6,507
Net Income From Discontinued Operations — — — —
Net Income From Total Operations -11,697 -12,326 -10,174 -6,507
Non Recurring Events
Extraordinary Income Losses — — — —
Income From Cummulated Effect Of Accounting Changes — — — —
Income From Tax Loss Carryforward — — — —
Other Gains And Losses — — — —
Total Net Income -11,697 -12,326 -10,174 -6,507
Normalized Income -11,697 -12,326 -10,174 -6,507
NetIncome Available For Common -11,697 -12,326 -10,174 -6,507
Preferred Dividends — — — —
Excise Taxes — — — —